Use of artificial intelligence in ophthalmology : a narrative review
BACKGROUND: Artificial intelligence (AI) deals with development of algorithms that seek to perceive one's environment and perform actions that maximize one's chance of successfully reaching one's predetermined goals.
OBJECTIVE: To provide an overview of the basic principles of AI and its main studies in the fields of glaucoma, retinopathy of prematurity, age-related macular degeneration and diabetic retinopathy. From this perspective, the limitations and potential challenges that have accompanied the implementation and development of this new technology within ophthalmology are presented.
DESIGN AND SETTING: Narrative review developed by a research group at the Universidade Federal de São Paulo (UNIFESP), São Paulo (SP), Brazil.
METHODS: We searched the literature on the main applications of AI within ophthalmology, using the keywords "artificial intelligence", "diabetic retinopathy", "macular degeneration age-related", "glaucoma" and "retinopathy of prematurity," covering the period from January 1, 2007, to May 3, 2021. We used the MEDLINE database (via PubMed) and the LILACS database (via Virtual Health Library) to identify relevant articles.
RESULTS: We retrieved 457 references, of which 47 were considered eligible for intensive review and critical analysis.
CONCLUSION: Use of technology, as embodied in AI algorithms, is a way of providing an increasingly accurate service and enhancing scientific research. This forms a source of complement and innovation in relation to the daily skills of ophthalmologists. Thus, AI adds technology to human expertise.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2022 |
---|---|
Erschienen: |
2022 |
Enthalten in: |
Zur Gesamtaufnahme - volume:140 |
---|---|
Enthalten in: |
Sao Paulo medical journal = Revista paulista de medicina - 140(2022), 6 vom: 14. Nov., Seite 837-845 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Martins, Thiago Gonçalves Dos Santos [VerfasserIn] |
---|
Links: |
---|
Themen: |
---|
Anmerkungen: |
Date Completed 11.11.2022 Date Revised 19.11.2022 published: Print Citation Status MEDLINE |
---|
doi: |
10.1590/1516-3180.2021.0713.R1.22022022 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM345610261 |
---|
LEADER | 01000naa a22002652 4500 | ||
---|---|---|---|
001 | NLM345610261 | ||
003 | DE-627 | ||
005 | 20231226025445.0 | ||
007 | cr uuu---uuuuu | ||
008 | 231226s2022 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1590/1516-3180.2021.0713.R1.22022022 |2 doi | |
028 | 5 | 2 | |a pubmed24n1151.xml |
035 | |a (DE-627)NLM345610261 | ||
035 | |a (NLM)36043665 | ||
035 | |a (PII)S1516-31802022000600837 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Martins, Thiago Gonçalves Dos Santos |e verfasserin |4 aut | |
245 | 1 | 0 | |a Use of artificial intelligence in ophthalmology |b a narrative review |
264 | 1 | |c 2022 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Completed 11.11.2022 | ||
500 | |a Date Revised 19.11.2022 | ||
500 | |a published: Print | ||
500 | |a Citation Status MEDLINE | ||
520 | |a BACKGROUND: Artificial intelligence (AI) deals with development of algorithms that seek to perceive one's environment and perform actions that maximize one's chance of successfully reaching one's predetermined goals | ||
520 | |a OBJECTIVE: To provide an overview of the basic principles of AI and its main studies in the fields of glaucoma, retinopathy of prematurity, age-related macular degeneration and diabetic retinopathy. From this perspective, the limitations and potential challenges that have accompanied the implementation and development of this new technology within ophthalmology are presented | ||
520 | |a DESIGN AND SETTING: Narrative review developed by a research group at the Universidade Federal de São Paulo (UNIFESP), São Paulo (SP), Brazil | ||
520 | |a METHODS: We searched the literature on the main applications of AI within ophthalmology, using the keywords "artificial intelligence", "diabetic retinopathy", "macular degeneration age-related", "glaucoma" and "retinopathy of prematurity," covering the period from January 1, 2007, to May 3, 2021. We used the MEDLINE database (via PubMed) and the LILACS database (via Virtual Health Library) to identify relevant articles | ||
520 | |a RESULTS: We retrieved 457 references, of which 47 were considered eligible for intensive review and critical analysis | ||
520 | |a CONCLUSION: Use of technology, as embodied in AI algorithms, is a way of providing an increasingly accurate service and enhancing scientific research. This forms a source of complement and innovation in relation to the daily skills of ophthalmologists. Thus, AI adds technology to human expertise | ||
650 | 4 | |a Review | |
650 | 4 | |a Journal Article | |
700 | 1 | |a Schor, Paulo |e verfasserin |4 aut | |
700 | 1 | |a Mendes, Luís Guilherme Arneiro |e verfasserin |4 aut | |
700 | 1 | |a Fowler, Susan |e verfasserin |4 aut | |
700 | 1 | |a Silva, Rufino |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Sao Paulo medical journal = Revista paulista de medicina |d 1994 |g 140(2022), 6 vom: 14. Nov., Seite 837-845 |w (DE-627)NLM074580345 |x 1806-9460 |7 nnns |
773 | 1 | 8 | |g volume:140 |g year:2022 |g number:6 |g day:14 |g month:11 |g pages:837-845 |
856 | 4 | 0 | |u http://dx.doi.org/10.1590/1516-3180.2021.0713.R1.22022022 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 140 |j 2022 |e 6 |b 14 |c 11 |h 837-845 |